MYSTIC (Meropenem Yearly Susceptibility Test Information Collection) results from the Americas: Resistance implications in the treatment of serious infections

Journal of Antimicrobial Chemotherapy

Volumn 46, Issue TOPIC T2, 2000, Pages 25-37

  Pfaller, Michael A ^a   Jones, Ronald N ^a   Ralston, K ^b   Della Latta, P ^c   Beavers May, T ^d   Jacobs, R ^d   Shoch, P ^e   Fader, R ^f   Tierno, P ^g   Bradley, J ^h   Jacobs, M ⁱ   Reynolds, M ^j   Peterson, L ^k   Mendes, C ^l   Zocolli, C ^m   Mimica, I ⁿ   Barriga, G ^o  

^a UNIVERSITY OF IOWA   (United States)

^b UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

^c NewYork Presbyterian Columbia University Irving Medical Center   (United States)

^d ARKANSAS CHILDREN S HOSPITAL   (United States)

^e WINTHROP UNIVERSITY HOSPITAL   (United States)

^f SPECTRUM HEALTH   (United States)

^g NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

^h RADY CHILDREN'S HOSPITAL   (United States)

ⁱ UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

^j Penrose Hospital   (United States)

^k NORTHWESTERN MEMORIAL HOSPITAL   (United States)

^l Fleury   (Brazil)

^m FEDERAL UNIVERSITY OF SANTA CATARINA   (Brazil)

ⁿ UNIVERSITY OF SÃO PAULO   (Brazil)

^o INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AMINOGLYCOSIDE; ANTIINFECTIVE AGENT; BACTERIAL ENZYME; BETA LACTAMASE; CARBAPENEM; CEFEPIME; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN;

ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIUM ISOLATE; BRAZIL; CONTROLLED STUDY; DATA ANALYSIS; DRUG ACTIVITY; DRUG POTENCY; GEOGRAPHIC DISTRIBUTION; HEALTH PROGRAM; HOSPITAL INFECTION; HUMAN; IN VITRO STUDY; MEXICO; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; STRAIN DIFFERENCE; UNITED STATES; WESTERN HEMISPHERE;

AMERICAS; ANTI-BACTERIAL AGENTS; DATA COLLECTION; DRUG RESISTANCE, MICROBIAL; GRAM-NEGATIVE BACTERIA; GRAM-POSITIVE BACTERIA; HUMANS; MICROBIAL SENSITIVITY TESTS; THIENAMYCINS;

EID: 0033833437     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Antimicrobial resistance in isolates from inpatients and outpatients in the United States: Increasing importance of the intensive care unit
2. The emergent needs for basic research, education, and surveillance of antimicrobial resistance
3. Bacterial resistance: A worldwide problem
4. Trends in antibiotic utilization and bacterial resistance: Report of the national nosocomial resistance surveillance group
5. Surveillance of anti-microbial use and antimicrobial resistance in United States hospitals: Project ICARE Phase 2
6. Evolution and dissemination of β-lactamases accelerated by generations of β-lactam antibiotics
7. Antibiotic-resistant bugs: When, where, and why?
8. Relationship between quinolone use and emergence of ciprofloxacin-resistant Escherichia coli in bloodstream infections
9. National Nosocomial Infections Surveillance (NNIS) system: Description of surveillance methods
10. Nosocomial infection rates in adult and pediatric intensive care units in the United States
11. Nosocomial blood stream infections in United States hospitals: A three-year analysis
12. Nosocomial enterococcal bloodstream infections in the SCOPE program: Antimicrobial resistance, species occurrence, molecular testing results, and laboratory testing accuracy
13. Staphylococcus aureus and coagulase-negative staphylococci from bloodstream infections: Frequency of occurrence, anti-microbial susceptibility, and molecular (mecA) characterization of oxacillin resistance in the SCOPE program
14. Inducible AmpC β-lactamase producing Gram-negative bacilli from bloodstream infections: Frequency, antimicrobial susceptibility, and molecular epidemiology in a national surveillance program (SCOPE)
15. Antimicrobial resistance in key bloodstream bacterial isolates: Electronic surveillance with the surveillance network database-USA
16. Survey of bloodstream infections due to Gram-negative bacilli: Frequency of occurrence and antimicrobial susceptibility of isolates collected in the United States, Canada, and Latin America for the SENTRY antimicrobial program, 1997
17. Trends in antimicrobial susceptibility of bacterial pathogens isolated from patients with bloodstream infections in the USA, Canada and Latin America
18. Bacterial pathogens isolated from patients with bloodstream infection: Frequencies of occurrence and antimicrobial susceptibility patterns from the SENTRY antimicrobial surveillance program
19. Survey of bloodstream infections due to Gram-positive cocci: Frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America for the SENTRY surveillance program
20. Contemporary antimicrobial susceptibility patterns of bacterial pathogens commonly associated with febrile patients with neutropenia
21. Antimicrobial susceptibility of bacteria causing urinary tract infections in Latin American hospitals: Results from the SENTRY antimicrobial surveillance program (1997)
22. The MYSTIC (meropenem yearly susceptibility test information collection) programme
23. Imipenem resistance in Klebsiella pneumoniae is associated with the combination of ACT-1, a plasmid-mediated AmpC β-lactamase, and the loss of an outer membrane protein
24. A review of the in vitro activity of meropenem and comparative antimicrobial agents tested against 30,254 aerobic and anaerobic pathogens isolated world wide
25. Meropenem in cystic fibrosis patients infected with resistant Pseudomonas aeruginosa or Burkholderia cepacia and with hypersensitivity to β-lactam antibiotics
26. Outer membrane proteins and susceptibility to carbapenems